Samantha J. Pearce - 10 Nov 2022 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
SVP, Head of Europe & Internat
Signature
By: /s/Adam Guttmann, as attorney in fact For: Samantha J Pearce
Issuer symbol
JAZZ
Transactions as of
10 Nov 2022
Net transactions value
-$48,420
Form type
4
Filing time
14 Nov 2022, 17:16:10 UTC
Previous filing
07 Sep 2022
Next filing
15 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Options Exercise $58,227 +532 +4.7% $109.45 11,841 10 Nov 2022 Direct
transaction JAZZ Ordinary Shares Sale $82,460 -532 -4.5% $155.00 11,309 10 Nov 2022 Direct
transaction JAZZ Ordinary Shares Options Exercise $58,118 +531 +4.7% $109.45 11,840 10 Nov 2022 Direct
transaction JAZZ Ordinary Shares Sale $82,305 -531 -4.5% $155.00 11,309 10 Nov 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JAZZ Non-Qualified Stock Option (right to buy) Options Exercise $0 -532 -5.6% $0.000000 9,031 10 Nov 2022 Ordinary Shares 532 $109.45 Direct F1, F2
transaction JAZZ Non-Qualified Stock Option (right to buy) Options Exercise $0 -531 -5.9% $0.000000 8,500 10 Nov 2022 Ordinary Shares 531 $109.45 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of March 2, 2020, 1/4th vested on the first anniversary of the vesting commencement date and the remainder vests in 36 equal monthly installments thereafter.